Antiretroviral Therapy with a Twice-Daily Regimen Containing 400 Milligrams of Indinavir and 100 Milligrams of Ritonavir in Human Immunodeficiency Virus Type 1-Infected Women during Pregnancy

Benzer Materyaller

• Pharmacokinetics of Indinavir at 800, 600, and 400 Milligrams Administered with Ritonavir at 100 Milligrams and Efavirenz in Ethnic Chinese Patients Infected with Human Immunodeficiency Virus
  Yazar:: Lee, Lawrence S., ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Week 48 efficacy of 900/100 mg daily of darunavir/ritonavir in treatment-experienced HIV-1 patients with virological success: DARDAR study
  Yazar:: Schneider, L, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Low Frequency of Intermittent HIV-1 Semen Excretion in Patients Treated with Darunavir-Ritonavir at 600/100 Milligrams Twice a Day plus Two Nucleoside Reverse Transcriptase Inhibitors or Monotherapy
  Yazar:: Lambert-Niclot, Sidonie, ve diğerleri
  Baskı/Yayın Bilgisi: (2010)
• Pharmacokinetics of Indinavir and Ritonavir Administered at 667 and 100 Milligrams, Respectively, Every 12 Hours Compared with Indinavir Administered at 800 Milligrams Every 8 Hours in Human Immunodeficiency Virus-Infected Patients
  Yazar:: Rhame, Frank S., ve diğerleri
  Baskı/Yayın Bilgisi: (2004)
• Genotypic Inhibitory Quotient as Predictor of Virological Response to Ritonavir-Amprenavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients
  Yazar:: Marcelin, Anne-Geneviève, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)